Wall Street Beat
Allergan board spurns Valeant’s $47B offer
Cardinal Health closes $320M AccessClosure buy
Cardinal Health (NYSE:CAH) said today that it closed its $320 million all-cash acquisition of AccessClosure and its Mynx extravascular closure technology.
The Mynx biodegradable sealant products are designed to close off the femoral artery and then dissolve within 30 days.
Abbott may look to expand medical device business footprint
K2M prices IPO under range at $132M
K2M Group cut the price on its initial public offering to $15 per share, with trading in the stock slated to begin today on the NASDAQ exchange under the KTWO symbol.
Teleflex announces plans to cut costs and streamline manufacturing | Medtech Wall Street news for the week of May 5, 2014
Medtronic exec: Google looms large as next great rival
Thoratec: NEJM article cost us market share
Is Siemens Healthcare headed for a spinout?
CareFusion ChloraPrep sales make a resurgence following kickbacks scandal
California-based CareFusion (NYSE:CFN) posted a strong 3rd quarter and narrowed its full-year sales outlook, touting strong sales growth, even for its controversial ChloraPrep surgical wipes.